Add this result to my export selection Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy - guidance (TA242) Source: National Institute for Health and Care Excellence - NICE (Add filter) 25 January 2012 Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination Read Summary Type: Guidance (Add filter)
Add this result to my export selection Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis - guidance (IPG681) Source: National Institute for Health and Care Excellence - NICE (Add filter) 28 October 2020 Evidence-based recommendations on pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis in adults. This involves spraying the inside of Read Summary Type: Guidance (Add filter)
Add this result to my export selection Cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis - guidance (IPG688) Source: National Institute for Health and Care Excellence - NICE (Add filter) 03 March 2021 Evidence-based recommendations on cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis. This involves Read Summary Type: Guidance (Add filter)
Add this result to my export selection Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer - guidance (IPG628) Source: National Institute for Health and Care Excellence - NICE (Add filter) 19 September 2018 Evidence-based recommendations on intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer in adults Read Summary Type: Guidance (Add filter)
Add this result to my export selection Chemotherapy Extravasation | ESMO Source: European Society for Medical Oncology - ESMO (Add filter) Management of chemotherapy extravasation: ESMO- EONS Clinical Practice Guidelines: J. A. Pérez Fidalgo, MD1, L. García Fabregat, RN1, A.... Type: Guidance (Add filter)
Add this result to my export selection Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal) - guidance (TA646) Source: National Institute for Health and Care Excellence - NICE (Add filter) 02 September 2020 NICE is unable to make a recommendation on glasdegib with chemotherapy for untreated acute myeloid leukaemia because Pfizer did not provide an evidence Read Summary Type: Guidance (Add filter)
Add this result to my export selection Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer - guidance (IPG638) Source: National Institute for Health and Care Excellence - NICE (Add filter) 30 January 2019 Evidence-based recommendations on electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer in adults Read Summary SPS comment Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
Add this result to my export selection Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) - guidance (TA240) Source: National Institute for Health and Care Excellence - NICE (Add filter) 14 December 2011 NICE is unable to recommend the use in the NHS of panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer.. Read Summary Type: Guidance (Add filter)
Add this result to my export selection Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment - guidance (DG16) Source: National Institute for Health and Care Excellence - NICE (Add filter) 10 December 2014 Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the Read Summary Type: Guidance (Add filter)
Add this result to my export selection Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer - guidance (DG34) Source: National Institute for Health and Care Excellence - NICE (Add filter) 19 December 2018 Evidence-based recommendations on tumour profiling tests to guide adjuvant chemotherapy decisions for people with early breast cancer. The tests are EndoPredict Read Summary Type: Guidance (Add filter) Type: Prescribing and Technical Information (Add filter)
